111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
View analysts' price targets and recommendations, and compare them with competitors.
$114.00
Lower downside than CX's downside of 16.39%.
Buy
Better than CX's analyst recommendation of Hold.
Analyze analyst forecasts for the company and compare them with competitors.
30.23B
Better than CX's estimated revenue of 14.32B.
4.98B
Better than CX's estimated ebitda of 2.52B.
2.14
Worse than CX's estimated eps of 8.76.
1.56B
Worse than CX's estimated net income of 6.38B.
3.30B
Better than CX's estimated ebit of 1.41B.
6.77B
Worse than CX's estimated sg&a expense of 2.66B.
Analyze DCF forecasts for the company and compare them with competitors.
36.27B
Better than CX's revenue of 860.88M.
6.80%
Worse than CX's revenue growth rate of 11.63%.
6.25B
Better than CX's ebitda of 161.25M.
17.23%
Worse than CX's ebitda margin of 18.73%.
4.56B
Better than CX's ebit of 100.21M.
12.56%
Better than CX's ebit margin of 11.64%.
1.69B
Worse than CX's depreciation of 61.05M.
6.58B
Better than CX's total cash of 30.89M.
18.14%
Better than CX's cash as percentage of revenue of 3.59%.
4.68B
Worse than CX's receivables of 86.69M.
12.90%
Worse than CX's receivables as percentage of revenue of 10.07%.
4.45B
Worse than CX's inventories of 88.57M.
12.28%
Worse than CX's inventories as percentage of revenue of 10.29%.
3.27B
Worse than CX's accounts payable of 153.93M.
9.01%
Better than CX's payables as percentage of revenue of 17.88%.
-1.89B
Better than CX's capital expenditure of -58.17M.
-5.20%
Worse than CX's capex as percentage of revenue of -6.76%.
9.67%
Worse than CX's weighted average cost of capital (wacc) of 9.27%.
10.90%
Worse than CX's cost of equity of 9.69%.
4.40%
Better than CX's cost of debt of 7.04%.
1.38
Worse than CX's beta of 1.12.
729.20M
Better than CX's diluted shares outstanding of 1.47B.
13.52B
Worse than CX's total debt of 404.20M.
68.33B
Better than CX's total equity of 8.15B.
81.85B
Better than CX's total capital of 8.55B.
16.51%
Worse than CX's debt weighting of 4.73%.
83.49%
Worse than CX's equity weighting of 95.27%.
3.61B
Better than CX's ebiat of 12.59M.
3.33B
Better than CX's unlevered free cash flow of 19.96M.
2.00%
Equal to CX's long-term growth rate of 2.00%.
56.34B
Better than CX's terminal value of 942.19M.
50.68B
Better than CX's enterprise value of 841.61M.
6.94B
Worse than CX's net debt of 373.30M.
43.74B
Better than CX's equity value of 468.30M.
59.98
Better than CX's equity value per share of 0.32.
